FDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
- The FDA has approved a new generic version of mifepristone, manufactured by Evita Solutions, which is approved for pregnancies up to ten weeks.
- U.S. District Judge Matthew Kacsmaryk transferred the abortion drug lawsuit from Texas to Missouri, allowing the anti-abortion medical coalition to continue their fight against mifepristone.
- Health and Human Services Secretary Robert F. Kennedy Jr. has announced a review of mifepristone's safety, responding to pressure from abortion opponents.
- Opposition from anti-abortion advocates has intensified, with statements condemning the FDA's actions as a betrayal of the pro-life movement, especially from figures like Former Vice President Mike Pence.
94 Articles
94 Articles
FDA approves another abortion pill after RFK Jr. pledged to review safety of mifepristone – outraging conservatives
The Food and Drug Administration (FDA) recently approved a new generic version of abortion pill mifepristone, a move conservatives are blasting as a “complete betrayal” after Health Secretary Robert F. Kennedy Jr., pledged a thorough safety review of the drug.
'Complete betrayal': Mike Pence melts down as Trump admin abandons major promise
Former Vice President Mike Pence melted down Thursday after President Donald Trump's administration approved a generic version of an abortion drug, thereby abandoning a key promise to a part of his base. The Food and Drug Administration on Thursday approved a generic version of mifepristone. The age...
Lawmakers Lay Into Trump's FDA After It Quietly Approves New Abortion Pill
Multiple GOP lawmakers blasted the Food and Drug Administration (FDA) following the agency’s greenlighting of a new abortion drug on Thursday. The flurry of criticism comes after the FDA approved of a new abortion pill from the drugmaker Evita Solutions, a company whose public mission is to “seek to normalize abortion care,” and “commit to […]
Coverage Details
Bias Distribution
- 51% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium